GlaxoSmithKline to pay $3bn in US drug fraud scandal
GlaxoSmithKline (GSK) is to pay $3bn (£1.9bn) in the largest healthcare fraud settlement in US history.
The drug giant is to plead guilty to promoting two drugs for unapproved uses and failing to report safety data about a diabetes drug to the Food and Drug Administration (FDA).
The settlement will cover criminal fines as well as civil settlements with the federal and state governments.
Michelle Fleury reports.
Most watched/listened
-
Saudi drivers in 'sidewalk skiing' craze
-
Zoo worker dies after tiger attack
-
Meet the ‘Queen of North Shields’
-
Police 'clean up' Mafia stronghold
-
MI5 'approached' Woolwich suspect
-
The memory man who cannot forget
-
Have mechanical clocks' time passed?
-
Preacher refuses to 'abhor' attack
-
The Queen and her passion for horses
-
Family tribute to soldier Lee Rigby
-
Footage from on board stricken plane
-
Burberry boss 'looking to Middle East'
-
Running barefoot in Wyoming
-
Porn: Parents 'should talk to children'
~RS~q~RS~~RS~z~RS~49~RS~)
